Table 1—

Patient characteristics

Baseline (prior to pump therapy)
1 year after pump start
Remained on pump therapyDiscontinued pump therapyRemained on pump therapyDiscontinued pump therapy
n1322913229
Age (years)13.9 ± 3.814.9 ± 2.614.9 ± 3.815.9 ± 2.6
Type 1 diabetes duration (years)7.2 ± 4.06.7 ± 3.88.2 ± 4.07.7 ± 3.9
Insulin dose (units · kg−1 · day−1)1.0 ± 0.31.1 ± 0.20.8 ± 0.20.9 ± 0.2
Daily BGM frequency4.1 ± 1.33.6 ± 0.6*4.7 ± 1.74.0 ± 1.2
A1C (%)8.4 ± 1.48.5 ± 1.48.0 ± 1.38.6 ± 1.3
z-BMI0.77 ± 0.640.89 ± 0.60.73 ± 0.70.95 ± 0.53
BMI22.2 ± 4.223.4 ± 3.522.8 ± 4.324.3 ± 3.4
Pubertal stage (%)
    Prepubertal (Tanner I)263§170
    Pubertal (Tanner II–IV)33453331
    Postpubertal (Tanner V)41525069
  • Data are means ± SD.

  • *

    * P = 0.002;

  • P = 0.05;

  • P < 0.05;

  • §

    § χ2(2) = 6.98, P = 0.03;

  • χ2(2) = 6.67, P = 0.04.